Home » Topics » BioWorld Science

BioWorld Science
RSS

TFF Pharmaceuticals initiates phase I study of voriconazole inhalation powder

Nov. 26, 2019

Antifilarial therapy against onchocerciasis presented

Nov. 26, 2019

Aziende Chimiche Riunite Angelini Francesco presents GSK-3beta inhibitors

Nov. 26, 2019

UCB discovers synaptic vesicle glycoprotein 2A/2C ligands

Nov. 26, 2019

Shanghai Institute of Materia Medica patents farnesoid X receptor agonists

Nov. 26, 2019

APRINOIA Therapeutics describes compounds targeting microtubule-associated protein tau

Nov. 26, 2019

New G12C mutant GTPase KRAS inhibitors identified at AstraZeneca

Nov. 26, 2019

HLX-07 displays antitumor activity in patients with advanced solid tumors

Nov. 26, 2019

In cancer cells, beware the vicious circle

Nov. 26, 2019

Binging brains give themselves away

Nov. 26, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...